Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electroconvulsive Therapy for Refractory Fibromyalgia: a Multicenter, Prospective, Randomized, Open-labelled, Wait-list Controlled Trial

NCT07835516 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT07835516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07835516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electroconvulsive Therapy for Refractory Fibromyalgia: a Multicenter, Prospective, Randomized, Open-labelled, Wait-list Controlled Trial
Lead sponsor
Beijing Tiantan Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
April 1, 2028
Enrollment
58 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia (fm)